New Hepatitis C Virus (HCV) Genotyping System That Allows for Identification of HCV Genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1997 Jan 1

PMID 8968908

Citations 140

Authors

O Ohno

M Mizokami

R R Wu

M G Saleh

K Ohba

E Orito

M Mukaide

R Williams

J Y Lau

Affiliations

Soon will be listed here.

Abstract

Recent studies have focused on whether different hepatitis C virus (HCV) genotypes are associated with different profiles of pathogenicity, infectivity, and response to antiviral therapy. The establishment of a simple and precise genotyping system for HCV is essential to address these issues. A new genotyping system based on PCR of the core region with genotype-specific PCR primers for the determination of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a was developed. A total of 607 samples (379 from Japan, 63 from the United States, 53 from Korea, 35 from Taiwan, 32 from China, 20 from Hong Kong, 15 from Australia, 6 from Egypt, 3 from Bangladesh, and 1 from South Africa) were tested by both the assay of Okamoto et al. (H. Okamoto, Y. Sugiyama, S. Okada, K. Kurai, Y. Akahane, Y. Sugai, T. Tanaka, K. Sato, F. Tsuda, Y. Miyamura, and M. Mayumi, J. Gen. Virol. 73:673-679, 1992) and this new genotyping system. Comparison of the results showed concordant results for 539 samples (88.8%). Of the 68 samples with discordant results, the nucleotide sequences of the HCV isolates were determined in 23, and their genotypes were determined by molecular evolutionary analysis. In all 23 samples, the assignment of genotype by our new genotyping system was correct. This genotyping system may be useful for large-scale determination of HCV genotypes in clinical studies.

Citing Articles

Therapeutic potential of salicylamide derivatives for combating viral infections.

Xu J, Xue Y, Bolinger A, Li J, Zhou M, Chen H Med Res Rev. 2023; 43(4):897-931.

PMID: 36905090 PMC: 10247541. DOI: 10.1002/med.21940.

Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV.

Campos L, de Almeida N, de Santana C, Barbosa E, Horta M, Amendola Pires M Viruses. 2023; 15(1).

PMID: 36680226 PMC: 9863677. DOI: 10.3390/v15010187.

Frequency and genotype distribution of hepatitis C virus infection in patients with diabetes type 2 in Ahvaz, Iran.

Makvandi M, Azaran A, Jalilian S, Parsa Nahad M, Azizolahi B, Neisi N Iran J Microbiol. 2021; 13(5):703-711.

PMID: 34900168 PMC: 8629818. DOI: 10.18502/ijm.v13i5.7437.

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.

Yamana Y, Kanda T, Matsumoto N, Honda M, Kumagawa M, Sasaki R J Clin Med. 2021; 10(23).

PMID: 34884231 PMC: 8658140. DOI: 10.3390/jcm10235529.

Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver?.

Abdel-Razik A, Shabana W, El Nakib A, Abdelsalam M, Abdelwahab A, Hasan A Front Cell Infect Microbiol. 2021; 11:662431.

PMID: 34660332 PMC: 8517490. DOI: 10.3389/fcimb.2021.662431.

References

Simmonds P, Holmes E, Cha T, Chan S, McOmish F, Irvine B . Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993; 74 ( Pt 11):2391-9. DOI: 10.1099/0022-1317-74-11-2391. View

Kuo G, Choo Q, Alter H, Gitnick G, Redeker A, Purcell R . An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989; 244(4902):362-4. DOI: 10.1126/science.2496467. View

Ohno T, Mizokami M, Tibbs C, Ohba K, Suzuki K, Wu R . New genotype of hepatitis C virus in South Africa. J Med Virol. 1994; 42(4):409-13. DOI: 10.1002/jmv.1890420414. View

Bukh J, Purcell R, Miller R . Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A. 1994; 91(17):8239-43. PMC: 44581. DOI: 10.1073/pnas.91.17.8239. View

Ohba K, Mizokami M, Ohno T, Suzuki K, Orito E, Ina Y . Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis. Virus Res. 1995; 36(2-3):201-14. DOI: 10.1016/0168-1702(95)00007-d. View

Kleter G, van Doorn L, Stuyver L, Maertens G, Brouwer J, Schalm S . Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western Europe. J Med Virol. 1995; 47(1):35-42. DOI: 10.1002/jmv.1890470108. View

Giannini C, Thiers V, Nousbaum J, Stuyver L, Maertens G, Brechot C . Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J Hepatol. 1995; 23(3):246-53. View

Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S . Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990; 87(17):6547-9. PMC: 54573. DOI: 10.1073/pnas.87.17.6547. View

Mizokami M, Gojobori T, Lau J . Molecular evolutionary virology: its application to hepatitis C virus. Gastroenterology. 1994; 107(4):1181-2. DOI: 10.1016/0016-5085(94)90245-3. View

10.

Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A . Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol. 1994; 21(3):468-73. DOI: 10.1016/s0168-8278(05)80330-7. View

11.

Lau J, Mizokami M, Kolberg J, Davis G, Prescott L, Ohno T . Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis. 1995; 171(2):281-9. DOI: 10.1093/infdis/171.2.281. View

12.

Nei M, Gojobori T . Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986; 3(5):418-26. DOI: 10.1093/oxfordjournals.molbev.a040410. View

13.

Alter H, Purcell R, Shih J, Melpolder J, Houghton M, Choo Q . Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989; 321(22):1494-500. DOI: 10.1056/NEJM198911303212202. View

14.

Mosley J, AACH R, Hollinger F, Stevens C, Barbosa L, Nemo G . Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA. 1990; 263(1):77-8. View

15.

Kaneko S, Unoura M, Kobayashi K, Kuno K, Murakami S, Hattori N . Detection of serum hepatitis C virus RNA. Lancet. 1990; 335(8695):976. DOI: 10.1016/0140-6736(90)91042-9. View

16.

Enomoto N, Takada A, Nakao T, Date T . There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 1990; 170(3):1021-5. DOI: 10.1016/0006-291x(90)90494-8. View

17.

Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H . The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 1990; 60(3):167-77. View

18.

Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T . Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990; 87(24):9524-8. PMC: 55204. DOI: 10.1073/pnas.87.24.9524. View

19.

Choo Q, Richman K, Han J, Berger K, Lee C, Dong C . Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991; 88(6):2451-5. PMC: 51250. DOI: 10.1073/pnas.88.6.2451. View

20.

Ogata N, Alter H, Miller R, Purcell R . Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A. 1991; 88(8):3392-6. PMC: 51453. DOI: 10.1073/pnas.88.8.3392. View